Cargando…
High-throughput flow cytometry screening of human hepatocellular carcinoma reveals CD146 to be a novel marker of tumor-initiating cells
Hepatocellular carcinoma (HCC) remains a common and lethal cancer. Cancer stem cells, or tumor-initiating cells (TICs), are thought to contribute to the pathogenesis of HCC, but remain to be fully characterized. Unbiased screens of primary human HCC cells for the identification of novel HCC TIC mark...
Autores principales: | Chen, Kui, Ding, Avrilynn, Ding, Yu, Ghanekar, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613743/ https://www.ncbi.nlm.nih.gov/pubmed/28955945 http://dx.doi.org/10.1016/j.bbrep.2016.08.012 |
Ejemplares similares
-
Dual‐Specificity Phosphatase 9 Regulates Cellular Proliferation and Predicts Recurrence After Surgery in Hepatocellular Carcinoma
por: Chen, Kui, et al.
Publicado: (2021) -
Endothelial cells do not arise from tumor-initiating cells in human hepatocellular carcinoma
por: Ghanekar, Anand, et al.
Publicado: (2013) -
Protocol for high-throughput compound screening using flow cytometry in THP-1 cells
por: Spangenberg, Stephan H., et al.
Publicado: (2021) -
The Application of Imaging Flow Cytometry to High-Throughput Biodosimetry
por: Wilkins, Ruth C., et al.
Publicado: (2017) -
flowCore: a Bioconductor package for high throughput flow cytometry
por: Hahne, Florian, et al.
Publicado: (2009)